Navigating Health Insurance, Medicaid, and the PA Process
Date: Friday, July 13th, 2018
Time: 12:00 p.m. – 12:30 p.m.
Solanlly Montero, Population Health Manager, CHW
Brookside Community Health Center
The first Journal Club of MABetterBreathing.org
Date: Monday, March 27th, 2017
Time: 12:30 p.m. – 01:00 p.m.
There has been a cloud over the use of long-acting beta-agonist bronchodilators, such as salmeterol (Serevent) and formoterol (Foradil), that are part of the combination inhalers Advair, Symbicort, and Dulera. Their use has been associated with an increased risk of death and near-death (ICU admission) from asthma, leading to a “black box” warning contained in the package insert of all of these inhalers. There has been a question about whether this risk of death and near-death applies to those who use these long-acting bronchodilators together with an inhaled steroid. The attached article describes a large study designed to answer this question.